Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

Cuttsy+Cuttsy campaign takes health literacy to the North Pole

White Papers and Resources | January 16, 2023 | Cuttsy + Cuttsy

Our 2022 Christmas campaign saw Santa’s agency elves creating tailored materials for patients. But were the examples guided by the principles of health literacy? Were they naughty or nice?

World-renowned creative icon Jeremy Perrott joins KVA

Press Releases | January 16, 2023 | KVA

KVA are excited to announce that Jeremy Perrott is joining the digital comms healthcare agency as a Board Advisor

Video: Strategic engagement case study

White Papers and Resources | January 13, 2023 | Inizio

Supporting the launch of a global vaccine with a programme of market research and strategic insights

Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

White Papers and Resources | January 13, 2023 | Inizio

Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.

Repurposing Off-Patent Drugs Through Crowd Funding

Videos and Podcasts | January 12, 2023 | Impetus Digital

Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies. 

The impact of mindset on digital product success: Download our new whitepaper

Press Releases | January 11, 2023 | Graphite Digital

Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...

SCIRIS ANNOUNCES APPOINTMENT OF NEW CEO

Press Releases | January 10, 2023 | Porterhouse Medical Group

Porterhouse extends a very warm welcome to Isaac Batley

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

White Papers and Resources | January 9, 2023 | Impetus Digital

It is no secret that Pharma (still) has a major diversity problem.

IGNIFI ANNOUNCES NEW LEADERSHIP TEAM FOR NEXT PHASE OF GROWTH

Press Releases | January 9, 2023 | IGNIFI

Creative healthcare marketing agency IGNIFI has announced its new senior leadership team, which includes the appointment of a new Managing Director for 2023 to lead the business into its next...

Research Partnership appoints new CEO

Press Releases | January 9, 2023 | Inizio

Research Partnership has appointed Gareth Phillips to take over as CEO